Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics

Zacks
02-12

For the quarter ended December 2024, Tenet Healthcare (THC) reported revenue of $5.07 billion, down 5.7% over the same period last year. EPS came in at $3.44, compared to $2.68 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $5.16 billion, representing a surprise of -1.75%. The company delivered an EPS surprise of +17.41%, with the consensus EPS estimate being $2.93.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Operating revenues: $5.07 billion compared to the $5.14 billion average estimate based on three analysts. The reported number represents a change of -5.7% year over year.
  • Net Operating revenues- Ambulatory Care: $1.26 billion versus $1.13 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +16.9% change.
  • Net Operating revenues- Hospital Operations and Services: $3.81 billion versus the three-analyst average estimate of $4 billion. The reported number represents a year-over-year change of -11.4%.
  • Adjusted EBITDA- Hospital Operations and Services: $518 million versus the three-analyst average estimate of $493.79 million.
  • Equity in earnings of unconsolidated affiliates: $78 million compared to the $80.11 million average estimate based on three analysts.
  • Adjusted EBITDA- Ambulatory Care: $530 million versus the two-analyst average estimate of $505.22 million.
View all Key Company Metrics for Tenet here>>>

Shares of Tenet have returned +8.8% over the past month versus the Zacks S&P 500 composite's +4.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Tenet Healthcare Corporation (THC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10